Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial
Sponsor: The Second Affiliated Hospital of Chongqing Medical University
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of liposomal Bupivacaine administered by paravertebral block for the treatment of acute and chronic pain after video-assisted thoracoscopic lobectomy.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
284
Start Date
2024-08-26
Completion Date
2025-08-31
Last Updated
2025-06-27
Healthy Volunteers
No
Conditions
Interventions
Liposomal bupivacaine
Participants randomized to the intervention arm received 266 mg of liposomal bupivacaine for paravertebral block before surgery.(The volume was expanded to 30 mL with normal saline).
Bupivacaine Hydrochloride
Participants randomized to the intervention arm received 0.5% 100 mg of bupivacaine hydrochloride for paravertebral block before surgery.(The volume was expanded to 30 mL with normal saline)
Locations (1)
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China